Andrej Bešše

1.0k total citations
35 papers, 636 citations indexed

About

Andrej Bešše is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Andrej Bešše has authored 35 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Hematology and 9 papers in Oncology. Recurrent topics in Andrej Bešše's work include Multiple Myeloma Research and Treatments (18 papers), Ubiquitin and proteasome pathways (16 papers) and Protein Degradation and Inhibitors (9 papers). Andrej Bešše is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Ubiquitin and proteasome pathways (16 papers) and Protein Degradation and Inhibitors (9 papers). Andrej Bešše collaborates with scholars based in Switzerland, Czechia and Netherlands. Andrej Bešše's co-authors include Ondřej Slabý, Marek Svoboda, Lenka Bešše, Rostislav Vyzula, Lenka Radová, Christoph Driessen, Pavel Fadrus, Jiří Šáňa, Jana Nekvindová and Marianne Kraus and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrej Bešše

30 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrej Bešše Switzerland 12 501 334 99 78 49 35 636
Alice Cani Italy 14 394 0.8× 121 0.4× 126 1.3× 120 1.5× 63 1.3× 26 645
Olubunmi Afonja United States 9 484 1.0× 112 0.3× 72 0.7× 51 0.7× 63 1.3× 18 610
Yanjun Gu China 11 348 0.7× 208 0.6× 166 1.7× 38 0.5× 77 1.6× 24 532
Conny Blumert Germany 7 469 0.9× 398 1.2× 117 1.2× 66 0.8× 134 2.7× 16 656
Sylvia Mahara Singapore 8 502 1.0× 179 0.5× 210 2.1× 65 0.8× 80 1.6× 9 658
Kaat Durinck Belgium 13 335 0.7× 178 0.5× 93 0.9× 98 1.3× 101 2.1× 26 548
Steven King United States 3 288 0.6× 130 0.4× 116 1.2× 54 0.7× 53 1.1× 8 469
Shunlin Jiang United States 10 349 0.7× 137 0.4× 104 1.1× 20 0.3× 59 1.2× 14 499
Lianne Gibson Canada 5 470 0.9× 180 0.5× 304 3.1× 28 0.4× 46 0.9× 5 647
Lloyd Pereira Australia 17 458 0.9× 110 0.3× 236 2.4× 21 0.3× 76 1.6× 25 659

Countries citing papers authored by Andrej Bešše

Since Specialization
Citations

This map shows the geographic impact of Andrej Bešše's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Bešše with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Bešše more than expected).

Fields of papers citing papers by Andrej Bešše

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrej Bešše. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Bešše. The network helps show where Andrej Bešše may publish in the future.

Co-authorship network of co-authors of Andrej Bešše

This figure shows the co-authorship network connecting the top 25 collaborators of Andrej Bešše. A scholar is included among the top collaborators of Andrej Bešše based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrej Bešše. Andrej Bešše is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Våtsveen, Thea Kristin, Andrej Bešše, Sigrid S. Skånland, et al.. (2025). Targeting proteostasis in multiple myeloma through inhibition of LTK. Leukemia. 39(9). 2237–2245. 1 indexed citations
2.
Bešše, Andrej, Christian Zuppinger, Christian Perez‐Shibayama, et al.. (2025). Carfilzomib-specific proteasome β5/β2 inhibition drives cardiotoxicity via remodeling of protein homeostasis and the renin-angiotensin-system. iScience. 28(9). 113228–113228.
3.
Bešše, Andrej, Lenka Bešše, Sara Christina Stolze, et al.. (2025). Abstract 2974: Bortezomib resistant multiple myeloma shows a specific dependency on Ecm29 in vitro and in vivo. Cancer Research. 85(8_Supplement_1). 2974–2974.
4.
Bešše, Lenka, Marianne Kraus, Andrej Bešše, Christoph Driessen, & Ignazio Tarantino. (2023). The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma. Scientific Reports. 13(1). 4411–4411. 5 indexed citations
5.
Bešše, Andrej, Marianne Kraus, Marija Buljan, et al.. (2023). Targeting IGF1R/Insr Pathway with Approved ALK-Inhibitors Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma. Blood. 142(Supplement 1). 4663–4663. 1 indexed citations
6.
Bešše, Andrej, et al.. (2022). Contribution of the Tumor Microenvironment to Metabolic Changes Triggering Resistance of Multiple Myeloma to Proteasome Inhibitors. Frontiers in Oncology. 12. 899272–899272. 11 indexed citations
7.
Bešše, Andrej, Marianne Kraus, Elmer Maurits, et al.. (2022). Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors. Cells. 11(5). 838–838. 4 indexed citations
8.
Bešše, Andrej, et al.. (2022). Mutant TP53 driving the Warburg Effect in Mantle Cell lymphoma. SHILAP Revista de lepidopterología. 10(10). e6296–e6296. 5 indexed citations
9.
Ring, Sandra S., Jovana Cupovic, Lucas Onder, et al.. (2021). Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment. Nature Communications. 12(1). 4734–4734. 21 indexed citations
10.
Bešše, Andrej, Lenka Bešše, Marianne Kraus, et al.. (2019). Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors. Cell chemical biology. 26(3). 340–351.e3. 84 indexed citations
11.
Šáňa, Jiří, Petr Bušek, Pavel Fadrus, et al.. (2018). Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Scientific Reports. 8(1). 2836–2836. 40 indexed citations
12.
Bešše, Andrej, Lenka Bešše, Sara Christina Stolze, et al.. (2017). Nelfinavir Blocks Export of Newly Synthesized Protein from the ER and Interacts with ER-Resident and Mitochondrial Proteins in an Activity-Dependent Fashion. Blood. 130. 3074–3074. 1 indexed citations
13.
Abt, Dominik, Andrej Bešše, Lenka Sedlaříková, et al.. (2017). Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus ( HIV )‐protease inhibitors lopinavir or nelfinavir. British Journal of Urology. 121(4). 600–609. 11 indexed citations
14.
Ondráček, Jakub, Pavel Fadrus, Jiří Šáňa, et al.. (2017). Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. Anticancer Research. 37(3). 1099–1104. 14 indexed citations
15.
Bešše, Andrej, Jiří Šáňa, Radek Lakomý, et al.. (2015). MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumor Biology. 37(6). 7719–7727. 52 indexed citations
16.
Šáňa, Jiří, Lenka Radová, Radek Lakomý, et al.. (2014). Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. Carcinogenesis. 35(12). 2756–2762. 30 indexed citations
17.
Bešše, Andrej, Jiří Šáňa, Pavel Fadrus, & Ondřej Slabý. (2013). MicroRNAs involved in chemo- and radioresistance of high-grade gliomas. Tumor Biology. 34(4). 1969–1978. 38 indexed citations
18.
Faltejsková, Petra, Marek Svoboda, Jitka Mlčochová, et al.. (2012). Identification and functional screening of microRNAs highly deregulated in colorectal cancer. Journal of Cellular and Molecular Medicine. 16(11). 2655–2666. 119 indexed citations
19.
Rédová, Martina, Alexandr Poprach, Andrej Bešše, et al.. (2012). MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumor Biology. 34(1). 481–491. 66 indexed citations
20.
Faltejsková, Petra, Andrej Bešše, Sabina Ševčı́ková, et al.. (2012). Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells. International Journal of Colorectal Disease. 27(11). 1401–1408. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Cani Breakdown of academic impact, for papers by Olubunmi Afonja Breakdown of academic impact, for papers by Yanjun Gu Breakdown of academic impact, for papers by Conny Blumert Breakdown of academic impact, for papers by Sylvia Mahara Breakdown of academic impact, for papers by Kaat Durinck Breakdown of academic impact, for papers by Steven King Breakdown of academic impact, for papers by Shunlin Jiang Breakdown of academic impact, for papers by Lianne Gibson Breakdown of academic impact, for papers by Lloyd Pereira
Rankless by CCL
2026